Rukobia tablet

Rukobia

fostemsavir (FTR)

DHHS recommendation not yet established
Entry Inhibitor

Standard Dose

Rukobia, approved July 2nd, is dosed as a 600 mg tablet taken twice daily with or without food. It must be taken in combination with other HIV antiretrovirals.

One 600 mg tablet twice daily without regard to food. For heavily treatment-experienced people with multidrug-resistant virus on a failing HIV regimen due to resistance, intolerance, or safety considerations. Must be taken in combination with another antiretroviral(s).

Take missed dose as soon as possible, unless it is closer in time to your next dose. Do not double up on your next dose.

See package insert for more complete information on potential side effects and interactions.

Tell your provider or pharmacist about all medications, herbals, and supplements you are taking or thinking of taking, prescribed or not, as there may be are other drug interactions which are not listed here.

Entry/attachment inhibitor: GP120 attachment inhibitor

Manufacturer

ViiV Healthcare
viivhealthcare.com
(877) 844-8872

AWP

$ 9.180.00/month

Potential Side Effects and Toxicity

Potential Drug Interactions

More Information

Doctor Comments

Activist Comments